Literature DB >> 17216740

Intracellular residency is frequently associated with recurrent Staphylococcus aureus rhinosinusitis.

I Plouin-Gaudon1, S Clement, E Huggler, C Chaponnier, P François, D Lew, J Schrenzel, P Vaudaux, J S Lacroix.   

Abstract

AIM: The prevalence of intracellular Staphylococcus aureus organisms in the nasal mucosa of patients with recurrent infectious rhinosinusitis episodes was studied.
METHOD: Twenty-seven consecutive adult patients who failed medical management of chronic rhinosinusitis (CRS) of multiple origins, associated or not with nasal polyposis, were consecutively enrolled for endonasal sinus surgery (including partial middle turbinectomy, middle antrostomy, ethmoidectomy, sphenoidotomy) and followed for a 12-month post-operative period.
RESULTS: Seventeen of these patients showed the presence of intracellular S. aureus as detected by confocal laser scan immunofluorescence microscopy in epithelial cells of surgical intranasal biopsy specimens. Nine of the patients with and two without intracellular bacteria yielded S. aureus in endoscopically guided cultures of middle meatus secretions, despite the recent administration of prophylactic antibiotics. Eleven of the 17 patients with intracellular S. aureus relapsed for rhinosinusitis within the 12-month follow-up period. Molecular typing of sequential S. aureus isolates demonstrated the persistence of unique patient-specific S. aureus clonotypes in nine of the patients with intracellular bacteria during the 12-month follow-up.
CONCLUSION: The presence of intracellular S. aureus in epithelial cells of the nasal mucosa is a significant risk factor for recurrent episodes of rhinosinusitis due to persistent bacterial clonotypes, which appear refractory to antimicrobial and surgical therapy.

Entities:  

Mesh:

Year:  2006        PMID: 17216740

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  24 in total

1.  Phagolysosomal integrity is generally maintained after Staphylococcus aureus invasion of nonprofessional phagocytes but is modulated by strain 6850.

Authors:  Thiên-Trí Lâm; Bernd Giese; Deepak Chikkaballi; Anika Kühn; Wanja Wolber; Jan Pané-Farré; Daniel Schäfer; Susanne Engelmann; Martin Fraunholz; Bhanu Sinha
Journal:  Infect Immun       Date:  2010-06-07       Impact factor: 3.441

2.  Canadian clinical practice guidelines for acute and chronic rhinosinusitis.

Authors:  Martin Desrosiers; Gerald A Evans; Paul K Keith; Erin D Wright; Alan Kaplan; Jacques Bouchard; Anthony Ciavarella; Patrick W Doyle; Amin R Javer; Eric S Leith; Atreyi Mukherji; R Robert Schellenberg; Peter Small; Ian J Witterick
Journal:  Allergy Asthma Clin Immunol       Date:  2011-02-10       Impact factor: 3.406

Review 3.  Chronic Rhinosinusitis and the Evolving Understanding of Microbial Ecology in Chronic Inflammatory Mucosal Disease.

Authors:  Michael Hoggard; Brett Wagner Mackenzie; Ravi Jain; Michael W Taylor; Kristi Biswas; Richard G Douglas
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  Screening for staphylococcal superantigen genes shows no correlation with the presence or the severity of chronic rhinosinusitis and nasal polyposis.

Authors:  Frédéric Heymans; Adrien Fischer; Nicholas W Stow; Myriam Girard; Zacharias Vourexakis; Antoine Des Courtis; Gesuele Renzi; Elzbieta Huggler; Stefan Vlaminck; Pierre Bonfils; Ranko Mladina; Valerie Lund; Jacques Schrenzel; Patrice François; Jean Silvain Lacroix
Journal:  PLoS One       Date:  2010-03-05       Impact factor: 3.240

5.  Intracellular persisting Staphylococcus aureus is the major pathogen in recurrent tonsillitis.

Authors:  Andreas E Zautner; Merit Krause; Gerhard Stropahl; Silva Holtfreter; Hagen Frickmann; Claudia Maletzki; Bernd Kreikemeyer; Hans Wilhelm Pau; Andreas Podbielski
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

6.  Short-term antibiotics treatment in patients with nasal polyps and enterotoxins producing Staphylococcus aureus strains.

Authors:  Petr Schalek; P Petrás; V Klement; A Hahn
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-22       Impact factor: 2.503

7.  In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: microbiology profiling studies with staphylococci and streptococci.

Authors:  Gregory T Robertson; Eric J Bonventre; Timothy B Doyle; Qun Du; Leonard Duncan; Timothy W Morris; Eric D Roche; Dalai Yan; A Simon Lynch
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

8.  Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.

Authors:  Sandrine Lemaire; Aurélie Olivier; Françoise Van Bambeke; Paul M Tulkens; Peter C Appelbaum; Youri Glupczynski
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

9.  Phenotype switching is a natural consequence of Staphylococcus aureus replication.

Authors:  Andrew M Edwards
Journal:  J Bacteriol       Date:  2012-08-03       Impact factor: 3.490

Review 10.  Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors?

Authors:  François Vandenesch; G Lina; Thomas Henry
Journal:  Front Cell Infect Microbiol       Date:  2012-02-16       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.